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Abstract

Betaine has been studied as an osmolyte and methyl group donor for many species.
Recent studies have found that betaine is able to increase muscle mass and reduce adiposity in
meat type broilers birds. In experiment one, eight-hundred Cobb 500 broiler chicks were
supplemented with betaine at 0.6 g/kg and 1.2g/kg. Birds had access to feed and water for ad
libitum consumption for forty-two, forty-four, and forty-nine days. Birds and feed were weighed
weekly. Carcass parameters (dress weight, breast percentage, and leg percentage) were taken at
slaughter on days forty- two and forty-nine. Blood was taken at day forty-four to assess nonesterified fatty acids, triglycerides and glucose. Betaine did not have an effect on carcass
performance, triglycerides or glucose. Betaine did however have a significant effect on NEFA
concentration (p<0.05) indicating a betaine induced change in lipolysis.
In experiment two, ten one day old broilers were used to establish a protocol for lipolysis
in broiler adipose explants. Adipose depots were harvested, cultured and treated with a variety of
known lipolytic agents and nuclear receptor agonists. Media concentrations of glycerol and
NEFA were measured to assess lipolytic activity of the explants. Treatments included: glucagon,
isobutyl-1-methylxanthine(IBMX),

isoproterenol,

betaine,

TO-901317,

GW-7647

and

rosiglitazone. Bezafibrate, IBMX, glucagon and TO-901317 had an significant effect on media
glycerol and non-esterified fatty acid concentration (p<0.05) indicating an increase in lipolysis.
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Chapter 1 Introduction
The poultry industry is under increased pressure to produce mass quantities of meat in a
fast and efficient manner. While the poultry industry is streamlined to produce meat efficiently,
there are certain metabolic inefficiencies that need to be overcome to produce a more profitable
animal. In the process of creating a leaner animal through diet manipulation, it is possible to find
solutions to our own metabolic shortcomings. Adipose tissue metabolism is a mystery that when
unraveled can provide answers and applications that range from the farm to the playground and
everywhere in between. The first step in understanding this mystery is to discover a method to
augment the metabolic process of the adipocyte. Lipolysis in the chicken; what works?
Betaine is a water soluble, naturally-produced organic base that has the potential to
improve tolerance of heat stress by both protecting against cellular dehydration and improving
lipid metabolism. In vivo, betaine is supplied by dietary sources and by the oxidation of choline.
Betaine plays a dual physiological role as both an important cellular osmolyte and a methyl
donor for the re-methylation of homocysteine to methionine.
Betaine’s osmotic importance stems from its accumulation within cells, where it
participates in the control of cell volume. As an osmolyte, betaine may have a stabilizing
function on cells subjected to osmotic disorders such as that which may occur in coccidiosis,
conditions where ionophores are used. Dehydration of cells occurs during infections and use of
betaine may have the potential to improve these conditions.
Metabolically, betaine affects lipid partitioning in the body. Betaine supplementation
reduces lipid deposition in liver, most clearly evidenced in its ability to reverse fatty liver in
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models of nonalcoholic fatty liver disease (Wang, Yao et al. 2010). Betaine has also been shown
to reduce deposition of abdominal adipose tissue in several animal models, including geese and
broiler chickens. Improved adiponectin levels, improved plasma insulin, and improved glucose
levels have been associated with betaine supplementation; implying that betaine has the potential
to improve adipose tissue function and insulin sensitivity (Wang, Yao et al. 2010). Greater fat
deposition in broilers selected for high body weight or high abdominal fat content is associated
with increased plasma concentrations of insulin and glucagon (Sinsigalli, McMurtry et al. 1987;
Dupont, Chen et al. 1999).
The second function of betaine is as that of a methyl donor. Betaine supplies methyl
groups for the re-methylation of homocysteine to methionine, a reaction catalyzed by betaine
homocysteine methyl transferase (BHMT). The dual functions of betaine as an osmolyte and as
a methyl donor are not mutually exclusive because BHMT is osmoregulated, with high tonicity
reducing its expression so that betaine metabolism decreases when osmolyte concentrations need
to be maintained (Schäfer et al. 2007). The conversion of homocysteine to methionine is
important to conserve methionine, detoxify homocysteine, and produce S-adenosylmethionine
(SAM)(Barak et al. 1996). S-adnenosylmethionine’s importance in fat metabolism is observed
in its role in phosphatidylethanolamine methyltransferase (PEMT) activity (Hoffman et al.
1981). The PEMT pathway synthesizes phosphatidylcholine, and is a vital step in the synthesis
and secretion of very low density lipoproteins (Noga et al. 2002).
Collectively, betaine supplementation may have dual benefit in conditions of heat stress
in poultry by both improving lipid metabolism and attenuating cellular dehydration. Beyond
heat stress, its impact on adipose physiology could benefit the broiler industry by reducing
carcass fatness and thus improving feed efficiency.
2

In addition, to betaine, there are other viable options to augment adipose metabolism in
chicken. In mouse models both hormonal and chemical treatments have stimulated lipolysis in
adipocytes. The major metabolic hormones glucagon and insulin have been shown to increase
and decrease lipolysis respectively. Chemical agents that include forskolin, isoproterenol and 3isobutyl-1methylxanthine (IBMX) have also demonstrated the ability to up regulate the lipolytic
pathway in various ways including the following: activation of adenylyl cyclase, up regulation
of cyclic AMP, and acting as an agonist to the β-adrenergic receptors.
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Chapter 2 Literature Review
Avian Metabolism

Carbohydrate metabolism in poultry is characterized by hyperglycemia and insulin
resistance (Vasilatos-Younken 1986). The glucose transporter type 4 (GLUT4), which is the
insulin responsive transporter in mamamls, is absent in some birds such as chicken and sparrow
(Seki et al. 2006; Sweazea and Braun 2006) but present in others such as ducks (Thomas-Delloye
et al. 1999). GLUT4 is responsible for insulin-regulated glucose transport into the cell.
In the fed state, glucose levels in adult poultry range from 190 to 220 mg/dl (Hazelwood
1986); juvenile plasma glucose levels range from 156 mg/dl to 330 mg/dl (Scanes 2008). Some
studies report that fasting does not affect circulating glucose concentrations (Belo et al. 1976;
Hazelwood and Lorenz 1959; Tinker et al. 1986) while others report the contrary (Harvey et al.
1978). However, there are small consistent decreases in circulating concentrations of glucose
following twenty-four hour feed withdrawal in meat type poultry (Edwards et al. 1999) .
It is evident that glucagon plays a role in maintaining glucose homeostasis in poultry.
Fasting results in an increase in plasma glucagon (Edwards et al. 1999). Glucagon is the major
lipolytic hormone in chickens (Campbell and Scanes 1987) and has been shown to reduce feed
intake in chicks (Honda et al. 2007). Insulin at high concentrations can depress glucagonstimulated lipolysis with chicken adipose tissue in vitro(Langslow and Hales 1969). Despite the
presence of circulating insulin at the expected levels, chickens present a status similar to
mammalian type 2 diabetic status possessing hyperglycemia and low sensitivity to exogenous
insulin (Akiba et al. 1999).
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The critical enzyme in gluconeogenesis is Phosphoenolpyruvate carboxykinase (PEPCK),
especially in the kidney. Adult female chicks lack PEPCK activity in the kidney while juvenile
birds possess PEPCK (Tinker et al. 1983). The enzyme retains its activity in the liver, but the
reduced activity of the enzyme over time indicates that gluconeogenesis efficiency decreases
throughout the bird’s lifetime.

Betaine
Betaine, the common name for trimethylglycine, is also known as glycine betaine, lycine
and oxyneurine (Craig 2012). Betaine was first discovered in the juice of the sugar beet (Beta
vulgaris) in the 19th century. It was then isolated in other organisms soon after. Betaine rich
foods, in order of concentration, include the following: wheat bran (1339 mg/100g), wheat germ
(1241 mg/100g), spinach (600-645 mg/100g), beets (114-297 mg/100g), pretzels (237 mg/100g),
shrimp (219mg/100g), wheat bread (201mg/100g), and crackers (49-199mg/100g). Betaine’s
function is to serve as an organic osmolyte to protect cells under stress or as a methyl donor,
which provides methyl groups for various biochemical pathways.
Betaine absorption occurs in the duodenum with serum concentration peaking at one to
two hours after ingestion (Craig 2012). Betaine is catabolized primarily in the liver and kidney,
and in these tissues a series of transmethylation reactions occur with the most important
transferring a methyl group from betaine to homocysteine (Craig 2012).

In this series of

reactions betaine is converted to dimethylglycine, and homocysteine becomes methionine (Craig
2012).

The remethylation of homocysteine is catalyzed by Betaine-homocysteine

methyltransferase (BHMT) (Li, Feng et al. 2008).
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As stated, one of betaine’s most important functions is that of a methyl donor. Therefore,
to understand Betaine’s role as a methyl donor its relationship with other methyl donors must
also be understood. Methionine and Choline are of particular interest because of the interplay
between the three compounds. All three are commonly added to poultry diets and betaine, a
metabolite of choline, has a slight sparing effect on choline (Dilger et al. 2007).

Choline
Historically choline, along with manganese, folic acid, nicotinic acid, and biotin, has
been added to feed to prevent perosis (slipped tendon), but it has also been proven that it is
needed in larger amounts than other vitamins because choline deficiency will result in decreased
growth, and poor feed utilization (Nesheim et al. 1979). Good sources of choline include: fish
meal, yeast, liver meal, and soybean oil meal (North 1984). Many phospholipids, including
phosphatidylcholine,

lysophosphatidylcholine,

sphyngomyelin,

plasmalogens, contain a choline constituent (Simon 1999).

lysosphyngomyelin

and

This is of importance because

phospholipids contribute to the integrity of the cell membrane (Simon 1999).
Choline most likely plays a role in fat metabolism because choline deficiency is
associated with the development of fatty liver due to a reduction in lipoprotein assembly (Simon
1999). Chicks may at times synthesize choline but at insufficient levels, therefore choline must
be added to starter rations (North 1984). Choline synthesis is a function of both age and sex.
Older birds synthesize more than younger birds, and hens produce more choline than roosters
(Nesheim et al. 1979; North 1984).
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One Carbon Metabolism
The major pathway associated with the exchange of methyl groups and the methyl donors
betaine, choline and methionine is the one catalyzed by BHMT. Choline is oxidized to betaine
by the enzyme choline oxidase.(Kidd et al. 1997). Hydrolysis of betaine generates one free
methyl group and a molecule of dimethylglycine. The free methyl group is transferred to
homocysteine by the action of BHMT and the dimethylglycine is further degraded to sarcosine
and glycine (Simon 1999). When methionine is deficient and there is an abundance of choline
and betaine; BHMT activity is increased (Emmert et al. 1996).
Conversion of choline to betaine is an inefficient process because choline must be
transported from the cytosol into the mitochondria before it can be oxidized to betaine (Kidd et
al. 1997). Betaine is then transported across the mitochondrial membrane into the cytosol where
it can function as methyl group donor (Mann et al. 1938). This makes choline conversion
especially difficult in chickens. Polyether ionophores are commonly used to control coccidiosis
in poultry, and these ionophores are known to interfere with mitochondrial membrane transport
of choline (Tyler 1977).

Betaine Hydroxy-methyltransferase

BHMT deficiency results in a general improvement in metabolic state by improving
glucose tolerance and insulin sensitivity in mice (Teng et al. 2012). In addition to the metabolic
improvement associated with BHMT deficiency, mice deficient in BHMT also possessed smaller
fat pads, with inguinal and gonadal fat up to 41% smaller than fat pads in wild type mice (Teng
et al. 2012). The small size of the fat depots can be attributed to smaller adipocyte size
7

(approximately 80% smaller) in BHMT deficient mice (Teng et al. 2012). These data along with
the increase in adipocyte number associated with deficient mice implies that adipocyte
differentiation was not affected by the deficiency but rather adipocyte storage and utilization of
triglyceride (Teng et al. 2012) . Overall energy usage is also altered by BHMT deficiency. Mice
genetically deficient in BHMT consumed the same amount of feed ,and showed no difference in
lipid absorption and excretion compared to wild type mice, but demonstrated increased O2
consumption and CO2 excretion throughout light and dark phases which is an indication of
increased energy usage (Teng et al. 2012).

BHMT null mice possessed a basal insulin

concentration that was about 50% less than control mice which indicates greater insulin
sensitivity, while other plasma measures including glycerol, non-esterified fatty acids, and
glucose showed no difference between genotypes (Teng et al. 2012). The BHMT deficient mice
also expressed a hyper metabolic phenotype which could be attributed to a 33% increase in
plasma thyroxine (T4) (Teng et al. 2012). BHMT knockout mice and wild type mice had similar
lipolytic rates (Teng et al. 2012). This is a curious finding because the knockout mice possess
smaller fat pads and increased energy expenditure. However, when treated with isoproterenol,
wild type and knockout mice demonstrated similar levels of triacylglycerol and glycerol, while
knockout mice demonstrated a 50% increase in plasma glucose concentration. The observed
glycerol concentration similarity was consistent with explant trials (Teng et al. 2012).
Betaine is currently used in the poultry industry to protect chicks from coccidiosis
because it can alleviate symptoms and improve performance (Fetterer et al. 2003). Betaine has
also been shown to cause a slight decrease in abdominal fat in broiler birds, when added to the
finishing diet (Xing et al. 2011). This decrease in adiposity may be attributed to betaine’s effect
on fibroblast growth factor (FGF21) expression. FGF21 is a recently discovered FGF and is
8

thought to regulate metabolism (Nishimura et al. 2000). Betaine hydroxyl-methyltransferase
deficiency results in an accumulation of betaine in tissues, and causes and increase in FGF21
expression.

This increase in FGF21 expression is thought to be due to increased energy

expenditure in mouse models (Teng et al. 2012). Betaine and its role in FGF21 expression are
ideal targets for lipolysis in the chicken because energy status is the key regulator for adipose
tissue metabolism (Ji et al. 2012).
Betaine is obtained naturally by both consumption of foods with high betaine and by the
conversion of choline to betaine. In fact betaine has a slight sparing effect on choline; betaine
can replace up to 50% of the dietary choline requirement (Dilger et al. 2007). Exposure to
specific stressors such as drought, high salinity, or temperature stress can trigger the synthesis of
betaine in mitochondria which subsequently increases betaine concentration within cells (Craig
2012). Osmoregulation is defined as the ability of a cell to maintain its structure and function by
regulating water movement in and out of the cell (Kidd et al. 1997). When betaine is not
catabolized, i.e. when cellular concentration increases within cells it is used as an organic
osmolyte. This function allows betaine to regulate the hydration state of a cell as well as
maintain cellular function (Craig 2012). Some metabolic pathways sensitive to a change in
hydration include protein turnover, amino acid metabolism, ammonia metabolism, carbohydrate
metabolism, fatty acid metabolism, plasma membrane transport, bile excretion, pH control and
gene expression (Häussinger 1996). Organic osmolytes such as betaine are favorable because
they do not have the detrimental effects of inorganic osmolytes.
osmolytes include potassium, magnesium and phosphate.

Inorganic intracellular

These osmolytes have a limited

function because high concentrations of inorganic osmolytes, caused by osmotic stress, can
affect metabolic function (Yancey PH 1982). High concentrations of sodium chloride and
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potassium chloride can alter the kinetics of enzymes within a cell but enzyme kinetics are not
affected in cells with high concentrations of organic osmolytes such as betaine and choline.
Therefore, in periods of prolonged hyperosmotic stress, cells will rely on the accumulation of
organic osmolytes to attenuate the effects of stress while avoiding the detrimental effects of
inorganic osmolytes (Burg 1994). Betaine is ideal as an additive to poultry feed because it is one
of the major organic osmolytes found to increase in the renal cells of the avian along with myoinositol, and taurine (Lien et al. 1993).

Ex Vivo Studies
In vitro experiments are ideal for focused metabolic experimentation because of the ease
with which pathways can be directly by pharmacological or nutrient treatments. In vitro studies
require minimal live animals, if any, for sample collection and the small scale of the experiments
require less treatment material without sacrificing power. A number of in vitro studies have been
done using adipose tissue explants and mature adipocytes. These experiments provide rationale
for ambitious in vivo trials.

Betaine
In humans, betaine supplementation alleviated insulin resistance in vitro (Kathirvel et al.
2010). Human HepG2 cells were made insulin resistant by exposure to high (30mM glucose) for
24 hours and induced with 10 nM insulin for ten minutes. The activation of protein kinase B in
these insulin resistant cells was reduced by 50% when compared to control models. Betaine
supplementation restored protein kinase B activation by fifty to one hundred percent depending
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on betaine concentration (Kathirvel et al. 2010) The cells grown in high glucose media also
possessed higher levels of phosphorylated 5’AMP- activated protein kinase (AMPK) (Kathirvel
et al. 2010). AMPK acts as a metabolic regulator and monitors energy stasis by sensing the
AMP: ATP ratio of the cell. AMPK phosphorylation suppresses fatty acid synthesis by inhibiting
acetyl- CoA carboxylase, the rate limiting enzyme in the fatty acid synthesis pathway (Kathirvel
et al. 2010). When there is high ATP in a cell the kinase is active signaling for the storage of fat.
When insulin resistant HepG2 cells were treated with betaine at varying concentrations AMPK
phosphorylation was suppressed. This suggests that betaine might reduce hepatic fat synthesis
(Kathirvel et al. 2010)
The effect of BHMT on adiposity has been demonstrated in vitro. BHMT deficiency
leads to impaired triacylglycerol synthesis and enhanced glucose oxidation in isolated mature
adipocytes, as well as impaired triacylglycerol oxidation in liver homogenates. Although fat
explants from both BHMT-deficient and wild type mice demonstrated the same rate of
triglyceride synthesis, BHMT-deficient mice synthesized sixty-two percent less triacylglycerol
(Teng et al. 2012).

Conjugated Linoleic acid

Conjugated linoleic acids (CLA) are a group of isomers of conjugated octadecadienoic
acid that occur naturally and are found in milk and in the meat of ruminants (Terpstra 2004).
The isomers which exhibit biological activity are CLA trans-10, cis-12(t-10,c-12) and CLA cis9 , trans-11(c-9,t-11)(Vyas et al. 2012). Conjugated linoleic acid has been acknowledged to have
numerous biological activities. Metabolically it has been shown to reduce lipid uptake in
adipocytes leading to changes in whole body composition (Oku et al. 2003; Park et al. 1997;
11

Park et al. 1999). Active isomers of CLA appear to reduce lipid in two ways. First, conjugated
linoleic acids inhibit fatty acid synthase, which limits fatty acid biosynthesis (Furlan et al. 2013).
Second, CLA reduces the activity of perilipin1, a coat protein of lipid droplets that plays a role in
lipolysis and lipogenesis of adipose tissues, which causes a reduction in white adipose tissue and
aberrant lipolysis in mouse tissue in vitro (Cai et al. 2012). In rats CLA can reduce epididymal
and retroperitoneal adipose depots by 26% and 53% respectively (Furlan et al. 2013). When
supplemented at 1.5% CLA diminished adipose tissue at a rate that caused difficulty in
harvesting adipose samples (Cai et al. 2012).
In humans, the effect of CLA on body composition and metabolism needs more
investigation. There is evidence that CLA can lower body fat mass in both obese and healthy
individuals (Blankson et al. 2000; Thom et al. 2001). However, it is unclear whether this
reduction in fat mass is due to exercise or the increased CLA intake.
While the benefit of CLA supplementation in humans is unclear, there are documented
cases of CLA’s usefulness in the agricultural sector. In cattle, average daily gain increased
significantly in animals supplemented with CLA at 1.72 kg/day in the form of linseed. However,
average daily intake and carcass classification (conformation and fat cover) were not affected by
CLA supplementation (Albertí et al. 2013). Similar findings have been reported in goats with no
effect on dry matter intake, body weight, milk yield, milk protein content, and lactose yield.
However, CLA has been shown to decrease milk fat yield, a function of de novo fatty acid
synthesis (Ghazal et al. 2012).
In poultry, CLA is used not as a metabolic regulator or carcass enhancer, but as an
immunity booster. Infectious bursal disease virus (IBDV) is a significant disease in the poultry
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industry because of its effect on the immune system and its virulence (Long et al. 2011).
Because CLA has been shown to alleviate immunosuppression it is the perfect weapon to combat
IBDV (Long et al. 2011). In chickens infected with IBDV, CLA significantly reduced mRNA
expression of inflammatory cytokines, interferon gamma and interleukin 6, as well as attenuated
the pathological changes in the bursa caused by IBDV (Long et al. 2011).
Although conjugated linoleic acid has a number of benefits it must also be noted that
there are significant side-effects to CLA supplementation. The trans-10, cis-12 isomer has been
shown to cause severe hyperinsulinemia and insulin resistance in mice, hamsters and pigs
(Bouthegourd et al. 2002; Clement et al. 2002; Roche et al. 2002; Stangl et al. 1999; TsuboyamaKasaoka et al. 2000).

Lipolysis
The adipocyte is the primary site of storage of fat for use as energy in times of negative
energy balance.

Free-fatty acids from the diet and from de novo fatty acid synthesis are

transported to the adipocyte and esterified to glycerol, a product of glucose metabolism, to form
a triglyceride molecule. These triglycerides are stored within the lipid droplet of the adipocyte.
In vertebrates, triacylglycerol-rich lipid droplets of adipocytes provide a major energy storage
depot for the body (Brasaemle 2007).
The ability to store energy in the form of triglycerides and the ability to use these energy
stores in times of low carbohydrate availability, or when metabolic demand is high, is a highly
conserved process across species and is essential for survival (Lampidonis et al. 2011). Obesity
occurs when energy intake exceeds energy need and there is a pathologic accumulation of white
adipose tissue (Zechner et al. 2005). Adipose tissue homeostasis is regulated by a number of
13

neural and hormonal signals, but the complexity of these pathways can be understood best if
viewed as the “metabolic equilibrium” between triglyceride synthesis and storage (Zechner et al.
2005). Adipose tissue lipolysis is the process of breaking down stored triglyceride within the
adipocyte resulting in the release of non- esterified fatty acid (NEFA) and glycerol (Lampidonis
et al. 2011).
It is widely accepted that a cyclic AMP-dependent mechanism is the rate-limiting step in
lipolysis in fat cells. The initial step in the process involves the hormonal activation of adenylate
cyclase which results in an increase in the production of cyclic AMP (cAMP) and increased
activation of cyclic AMP-dependent protein kinase (protein kinase A; PKA) and the subsequent
phosphorylation and activation of hormone sensitive lipase (Belfrage et al. 1982). Cyclic AMP
can be increased hormonally by glucagon or chemically by isoproterenol or forskolin (Allen et
al. 1986; Ravnskjaer et al. 2013).
In most species hormone sensitive lipase is one of the major targets of this regulation.
Binding of agonists to the β-adrenergic receptors, coupled to adenylate cyclase leads to
activation of protein kinase A which in turn phosphorylates HSL and stimulates lipolysis (Holm
2003). In vitro, phosphorylation of hormone sensitive lipase by PKA can be monitored as an
increased activity against triglycerides and cholesteryl ester substrates. In vivo, phosphorylation
via PK A results in the translocation of HSL from a cytosolic location, to the surface of the lipid
droplet (Clifford et al. 1997; Egan et al. 1992).
In addition, to HSL, perilipin proteins are major targets for PKA phosphorylation upon βadrenergic stimulation of adipocytes. Perilipins are a family of closely related proteins that are
abundantly expressed on the surface of adipocytes (Londos et al. 1999). The role of perilipin in
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PKA-mediated lipolysis is apparent in perilipin null mice. These mice demonstrated= attenuated
β-adrenergic-induced lipolysis (Holm 2003). Perilipin appears to play a dual role as suppressor
of basal lipolysis and as a necessary component for full lipolytic stimulation to occur (Souza et
al. 1998). It has also been demonstrated that without fully functioning perilipin A, translocation
of hormone sensitive lipase to the lipid droplet cannot occur (Sztalryd et al. 2003).
Adipocyte lipolysis is regulated hormonally and HSL is one of the major targets of this
regulation (hence its name). Insulin is believed to be the most important anti-lipolytic hormone
in mammals. In most species, insulin inhibits lipolysis in adipocytes through inhibition of
hormone sensistive lipase (Anthonsen et al. 1998). This is because of insulin’s ability to lower
cAMP levels and thus PKA activity.

Insulin accomplishes this through activation of

phosphodiesterase 3B (Shakur et al. 2001). The anti-lipolytic activity of insulin can be countered
with the treatment of a phosphodiesterase inhibitor such as 3-isobutyl-1-methylxanthine (IBMX).
Phosphodiesterases degrade cAMP and control its levels within the cell. Persistent elevation of
cAMP due to treatment with IBMX prevents insulin-mediated suppression of lipolysis (Makino
et al. 1992).
There are also a number of nuclear hormone receptors that could affect lipolysis.
Peroxisome proliferator activated receptors (PPARs) are the most important of these receptors, in
particular PPARγ. Activated PPARγ increases the expression of key adipogenic genes that
promote the storage of fatty acids and decreases the expression of lipolytic genes (Ferre 2004).
The formation of preadipocytes from mesenchymal stem cells, as well as differentiation of
preadipocytes, is dependent on the activation of PPARγ (Rosen et al. 1999)
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Another nuclear receptor associated with lipid metabolism is the liver X receptor alpha
(LXRα). There is a relationship between inflammation and lipid metabolism and the LXR
family of receptors integrate metabolic and inflammatory signaling (Bensinger et al. 2008). The
liver X receptors (LXRα and LXRβ) control intracellular sterol and lipid homeostasis by
regulating the genes involved in cholesterol transport, disposal, lipogenesis and glucose
metabolism.(Laurencikiene and Ryden 2012) Oxysterols, oxidized derivatives or cholesterols,
serve as ligands to activate LXRs. (Archer et al. 2013; Laurencikiene and Ryden 2012). The role
of LXRα is well documented within the liver but it is not well understood how LXRα influences
lipid metabolism in white adipose tissue (WAT). Both LXRα and LXRβ are expressed in WAT
(Steffensen et al. 2003).

In mice, activation of LXRα with a synthetic ligand resulted in

increased lipogenesis and increased storage of lipid in sub-cutaneous adipose depots (Archer et
al. 2013) However, activation of LXRα by use of agonists have been shown to increase lipolytic
rates in other species (Cruz-Garcia et al. 2012).
Previous work in our lab has found that the release and oxidation side of the balance
equation are also important determinants of fatness in chickens. There is evidence that as
leanness increases, circulating non-esterified fatty acids and the rate of fatty acid oxidation also
increase. Genetically lean lines of chickens have higher levels of lipolysis and increased fatty
acid oxidation in adipose tissue (Ji et al. 2012). These studies serve as the basis for the current
investigation of the efficacy of lipolysis as a method for carcass modification in broilers.
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Chapter 3 Materials and Methods
In Vivo Supplementation
Experimental Rationale
Betaine has been shown to reduce adiposity and increase breast weight in broilers in the
absence of methionine (Zhan et al. 2006). However it is not clear how betaine affects the whole
bird in a diet with normal methionine. It is also important to note that Zhan and others did not
study betaine in the absence of other methyl group donators(Zhan et al. 2006). Therefore, it is
important to test the effects of betaine when added to a normal poultry ration. Because betaine
appears to be a suitable replacement for methionine as far as growth is concerned, it is assumed
that when combined, with methionine, betaine will result in an increase in lean growth and
decrease in adiposity.

Experimental Design
Eight hundred, one day-old mixed sex broiler chicks (Cobb 500), obtained from Pilgrims
Corporation (Cohutta,Georgia), were weighed in groups of 10, wing-banded, and assigned to
floor pens across two rooms. Each room represented different growth environments. Eight
replicated pens were assigned to each of five dietary treatments. Mash diets were prepared from
a corn-soybean meal based common diets. Phase feeding was carried out in which a starter diet
(3038 kcal/kg,, 21% protein) was fed from day 1 to day 21, a grower diet (3077 kcal/kg, 20%
protein) from day 22 to day 38 and a finisher diet (3124 kcal/kg, 18% protein) from day 39 to
termination of the study. The basal diet for all treatments was formulated to meet NRC
requirements, with some nutrients at greater levels to match levels in typical commercial diets;
however, methionine and choline were set to NRC levels. Dietary treatments were as follows:
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1. Control - basal diet with choline level formulated to NRC level
2. Choline 1 – basal diet supplemented with choline chloride to provide 500 ppm of methyl
equivalent.
3. Choline 2 - basal diet supplemented with choline chloride to provide 1000 ppm of methyl
equivalent.
4. Betaine 1- basal diet supplemented with betaine to provide 500 ppm of methyl
equivalent.
5. Betaine 2 - basal diet supplemented with betaine to provide 1000 ppm of methyl
equivalent.

Feed and water were provided ad libitum throughout the experiment. Chicks were grown
in a 23 hour light: 1 hour dark cycle with incandescent light supplementation. Birds were group
weighed once weekly. Any birds that died during the experiment were weighed and the date of
death and the weight of the bird were recorded and added to the group weight for that week.
Starting on day 22, one of the temperature-controlled rooms was maintained at 23.9° C
(thermo-neutral) while the temperature in the other room was cycled between 23.9° C and 33 °C
(heat stress) in eight hour intervals. Body weight was monitored weekly and used to determine
weight gain. Blood was collected at weeks four and five from birds that were slaughtered at
weeks six and seven, respectively, and again at day 44 from birds that were not slaughtered.
Blood was allowed to clot for at least 30 minutes and then centrifuged to separate serum, which
was collected and stored at -20oC until use for assays.

The resultant serum was used to

determine the effect of treatment on lipid metabolism.
Measures of non-esterified fatty acids (NEFA), triglyceride content, glucose and glycerol
were perfromed using commercial assay kits. Non esterified fatty acids were analyzed using HR
Series NEFA-HR(2) (Wako Chemicals USA, Richmond, Virginia). The NEFA assay relies on
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the acylation of coenzyme A (CoA)by the fatty acids in the presence of added acyl- CoA
synthetase (ACS). The acyl-CoA is oxidized by added acyl- CoA oxidase with the generation of
hydrogen peroxide. Hydrogen peroxide, with peroxidase permits the condensation of 3-methylN-ethyl-N-(β-hydroxyethyl)-aniline (MEHA) with 4-aminoantipyrine to form a purple colored
product which can be measure colorimetrically at 550 nm. The levels of NEFA represent the
amount of fatty acids that are not bound to a glycerol backbone and indicate the level of
lipolysis occurring in the animal. NEFA is presented in milligrams per deciliter (mg/dl)
Triglyceride content was analyzed using L-Type TG M (Wako Chemicals USA,
Richmond Virginia). Serum triglycerides indicate the level of lipid available to the body via the
circulation. The triglyceride assay works similarly to the NEFA assay but relies on the
decomposition of glycerol to glycerol-3-phosphate. Glycerol is converted to glycerol-3phosphate by glycerol kinase in the presence of adenosine-5’-triphosphate (ATP). Glycerol-3phosphate formed is oxidized by glycerol-3-phosphate oxidase in a reaction that produces
hydrogen peroxide. The hydrogen peroxide produced causes HMMPS and 4-aminoantipyrine to
undergo a oxidative condensation catalyzed by peroxidase (POD), producing a blue pigment.
Glucose was measured using the Glucose Colorimetric Assay Kit (Cayman Chemical, Boston,
Massachusetts).

The glucose assay uses the glucose oxidase peroxide reaction for the

determination of clucose concentration. In this reaction glucose is oxidized to δ-gluconolactone
with simultaneous reduction of glucose oxidase.. the reduced glucose oxidase is regenerated to
its oxidized form by molecular oxygen to produce hydrogen peroxide.
peroxidase

catalyzed

a

reaction

between

hydrogen

peroxide

and

Then horseradish
3,5-dichloro-2-

hydroxybenzenesulfonic acid and 4-aminoantipyrine to generate a pink color that can be
measured coloremetrically at 514 nm and expressed as (mg/dl) Glucose utilization represents the
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overall metabolic state of the animal. Glycerol content was measured using the free glycerol
reagent (Sigma-Aldrich, St. Louis, Missouri).

The Free Glycerol Reagent measures free,

endogenous glycerol using coupled enzyme reactions. Glycerol is phosphorylated by adenosine5-triphosphate (ATP) forming glycerol-1-phosphate (G-1-P) and adenosine-5-diphosphate
(ADP) in the reaction catalyzed by glycerol kinase (GK). G-1-P is then oxidized by glycerol
phosphate oxidase (GPO) to dihydroxyacetone phosphate (DAP) and hydrogen peroxide.
Peroxidase (POD) catalyzes the coupling of hydrogen peroxide with 4-aminoantipyrine (4-AAP)
and sodium N-ethyl-N-(3-sulfopropyl) m-anisidine (ESPA) to produce a purple dye that can be
measured at 540 nm and is expressed in milligrams per milliliter (mg/ml)

Serum gycerol

concentration serves as an additional measure of lipolysis, in conjunction with NEFA
measurement. Glycerol and NEFA should have a positive relationship, with an expected ratio of
three molecules of NEFA for each molecule of glycerol.
On day 42 and again on day 49, following a 12-hour fast, three birds from each pen were
randomly selected, slaughtered and processed into market parts. The carcass was divided into
leg quarter and breast portions and part yield was calculated as percent of the whole carcass. On
day 44, sixty birds of the same sex were euthanized and blood, abdominal fat and liver were
collected, weighed, and preserved for downstream analyses.

Statistical Analysis:
The experiment was a completely randomized split-plot design, with temperature in the
whole plot and treatment applied to pen sub-plot experimental units. Response variables were
treated as repeated measures and added to the model; all analyses used mixed model analysis of
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variance (SAS 9.2, Cary, NC). Least squares means were compared using Fisher's protected
LSD and differences considered significant at the 5 % level of probability. Data were examined
for normality using the Shapiro-wilk test for normality and equal variance . Correlation analyses
were used to study relationships among the response variables.

In Vitro Stimulation of Lipolysis
Experimental Rationale
Whole body physiology is complex and there is still much to be learned about the
chicken in general.

With that in mind it is intuitive that the lipolytic pathway should be

understood on a cellular or tissue level to make in vivo manipulation of lipolysis more efficient.
Lipolysis is regulated by a cAMP dependent mechanism (Belfrage et al. 1982). Therefore, up
regulation of cAMP either through increased production via adenylate cyclase or inhibition of
phosphodiesterase degradation of cAMP should increase the rate of lipolysis within the
adipocyte. For that reason, treatments were chosen that would have either a direct or indirect
influence on cAMP concentration.
Before treatment could begin the appropriate experimental material had to be identified.
We chose to develop a model using adipose tissue explants, which are small pieces of intact
adipose tissue maintained in tissue culture media ex vivo. Explant cultures, unlike isolated
primary adipocytes or preadipocytes, maintain the cell-cell communication among multiple cell
types that is present in adipose tissue. . To maintain the same level of glycemia in which the
tissue functioned in vivo, the glucose concentration of the tissue culture media was altered to
approximate the glycemic status of a few chicken.
21

Experimental Design
Ten one day-old broiler chicks were obtained from Hubbard Cooperation (Pikeville, TN).
At seven days of age, chicks were weighed and wing-banded. Commercial starter chick ration
was used. Feed and water were provided ad libitum throughout the experiment. Chicks were
grown in a 23 hour light:1 hour dark cycle with incandescent light supplementation. Chicks
were euthanized with carbon dioxide and adipose tissue was harvested and cultured for
experiments, as described below.
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Collection and Processing of Adipose Tissue Explants for Tissue Culture
Materials
Adipose Tissue Collection
1. Sterile scalpel and scissors
2. Sterile 50 ml tubes
3. 37°C water bath
4.

Warm transport medium ( M199(Sigma-Aldrich, St. Louis, Missouri )with penicillin
and streptomycin or PBS)

5. 70% ethanol
6. Chlorohexidine
7. Sterile 4x4 gauze
8. Gloves
9. Two 1 liter beakers

Explant Culture
1. Sterile tubes
2. Sterile scissors and forceps
3. Tissue culture incubator set at 37°C 95% O2 and 5% CO2
4. 37°C water bath
5. M199 media supplemented with Pennicillin/streptomycin and glucose at a
concentration of 15mM
6. Amphotericin B
7. 100mm tissue culture dish
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8. 100mm petri dish
9. Laminar flow hood

Methods
Adipose Tissue Collection
1. Warm 50 ml of transport medium in water bath. Once media is warm, weigh the tube.
2. Euthanize the chicken.
3. Wash the carcass and remove any debris.
4. Pluck the feathers around the dissection area. The fat pad is located between the keel
(breast bone) and the vent (cloaca) of the bird. Thoroughly remove all feathers from
the area. It is ideal to remove the feathers from the legs as well.
5. Soak sterile 4x4 gauze pads in beakers, one containing 70% ethanol and one
containing chlorohexidine.
6. Clean the plucked area with chlorohexidine first. Allow approximately 2 minutes of
contact. Next wash the area using the 70% ethanol soaked 4x4. Change gloves after
completing this step.
7.

Make an incision and remove the skin until adipose tissue is visible. Resect as much
tissue as possible without contaminating tissue with gut contents.
*Steps 8-9 optional*

8. Wash tissue in 70% ethanol for 10 seconds followed by a PBS wash
9. Place tissue in warmed transport media and weigh. Use this weight and the weight of
the tube without fat to calculate adipose tissue yield.
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Explant Culture
1. Calculate the number of dishes based on weight of the tissue harvested. Dishes
should not exceed (500mg/100mm dish). This proportion of tissue to media can be
scaled down to accommodate smaller plates if needed. Examples: (150-250mg/60mm dish or 50-100mg/35-mm dishes).
The following steps take place in laminar flow hood as sterile conditions are required.
2. Calculate and prepare culture media (15ml-media/ 100mm dish). Warm the media in
37° C water bath
*optional* add antimycotic. Amphotericin B at a concentration of 25ug/ml
works well.
3. Pour transport media and harvested tissue into petri dish. (Don’t overfill the petri
dish. This dish is just for tissue processing)
4. Mince the tissue into approximately 20mg pieces.
5. Distribute the tissue uniformly to 100mm tissue culture plates containing 15ml of
media.
6. Incubate in cell culture incubator 37°C under 5% CO2/95% O2.
7. Change the media 24 hours after plating and again 48 hours after plating. This allows
the tissue to recover from the collection process.
8. Calculate and prepare treatment media using the recovery media as a base.
9. Incubate and harvest accordingly.

25

Treatment of Adipose Explants
Explants were harvested and cultured using the protocol explained previously. After the
48 hour rest, explants were treated with the following:

Table 1. Treatments and concentrations for in vitro stimulation of lipolysis
Treatments

Concentration

Function

Solvent

Source

betaine

2mM and 20mM

Osomoprotectant,
methyl donation

water

SigmaAldrich,

IBMX

500nM and 100nM

Phosphodiesterase
inhibitor

water

SigmaAldrich

methylxanthine)
glucagon

100nM and 500nM

isoproterenol

10μM and 1μM

50mM
acetic acid
water

TO-901317

1μM and 10μM

GW-7647

1μ and 10mM

Major lipolytic
hormone
Β-adrenergic receptor
agonist
Liver X receptor
agonist
PPAR alpha agonist

bezafibrate

1μM and 10mM

PPAR delta agonist

DMSO

rosiglitazone

1μM and 10μM

PPAR gamma agonist

DMSO

SigmaAldrich
SigmaAldrich
SigmaAldrich,
Cayman
Chemical
Cayman
Chemical
SigmaAldrich,

(isobutyl-1

DMSO
DMSO

The treatments, concentrations and functions of various agents used to stimulate lipolysis in
broiler adipose explants. All treatments contained glucose at a concentration of 15mM.

The treatments were grouped into two categories, nuclear receptor agonists and lipolytic
agents. The nuclear receptors experiments included T0-901317, GW-7647, bezafibrate and
rosiglitazone. The lipolytic agent experiments included betaine, IBMX, glucagon, forskolin and
isoproterenol. Experiments performed were as follows:
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Table 2. In vitro experiments
Experiment

Treatments

Time Points

Lipolytic Agent 1

isoproterenol, glucagon, forskolin, IBMX

1 hour, 6 hours

Lipolytic Agent 2

betaine, IBMX, glucagon

1 hour, 6 hours

Lipolytic Agent 3

betaine, IBMX, glucagon

1 hour , 6hours

Nuclear Receptor 1

rosiglitazone, TO-901317

1 hour, 24 hours

Nuclear Receptor 2

rosiglitazone, TO-901317,bezafibrate, GW-7647

1 hour, 6 hours

Nuclear Receptor 3

rosiglitazone, TO-901317, bezafibrate, GW-7647

24 hours

A list of each experiment performed, the treatments used and the time points at which media or
fat was collected and stored for analysis.

Media was collected at each time point and explants were weighed and either preserved
in RNAlater (Qiagen.com) or snap frozen in liquid nitrogen for RNA isolation at a later date.
Non-esterified fatty acids and glycerol were measured using commercial kits. Non esterified
fatty acids were analyzed using HR Series NEFA-HR(2) (Wako Chemicals USA, Richmond,
Virginia) and glycerol content was measured using the free glycerol reagent (Sigma-Aldrich, St.
Louis, Missouri).
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Chapter 4 Results
In Vivo Supplementation of Betaine
The whole carcass weight, (weight after de-feathering and evisceration) is presented in
Table 3 as dress weight. There was no significant difference in dress weight between treatments
(p>0.90). Figure 1 represents the effects of interaction between treatment and temperature on
dress weight. There was no significant effect of temperature and treatment interaction on dress
weight (p>0.60).
The carcass was divided into market parts of leg quarter and breast. The data are
presented in Table 4 and Table 5, respectively. While there was not a treatment effect on leg
weight ( p>0.70) or breast weight (p>0.50) there was a trend associated with temperature effect
on leg weight (p< 0.10). Abdominal fat pad weight is presented in Table 7. There was not a
significant effect of treatment (p>0.30) or temperature (p> 0.80) on fat pad weight.
The weights of the market parts were also analyzed as a percentage of dress weight. The
data are presented in the appropriate Table. While the effect of treatment on breast and leg
percentage was not significant, there was a trend associated with the effect of temperature on leg
and breast percentage (p<0.10). Total muscle percentage is presented in Table 5. There was no
appreciable difference across treatments (p>0.20) or temperature (p>0.30).
Figures 1-4 represent the interaction of temperature and treatment on the weight of leg
quarters, breasts and abdominal fat. There was no significant difference or trend observed in the
effect of temperature on carcass parameters.
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Table 3. Whole carcass weight for experiment 1

Treatment
1
2
3
4
5
Temperature
High Temperature
Thermoneutral

Dress weight
2210.69a
2223.65a
2213.73a
2247.67a
2218.86a

SEM
37.35
38.35
38.35
37.10
37.91

2217.82a
2228.02a

23.99
23.84

Data are least square means
a
Values within same column not sharing letters are different (p<0.05)
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Dress Weight
2500

A

A

A

A

A

A

A

A

A

A
1 HS

2000

1 TN

Grams (g)

2 HS
1500

2 TN
3 HS
3 TN

1000

4 HS
4 TN
500

5 HS
5 TN

0

Temperature x treatment

Figure 1 Interaction between treatment and temperature on dress weight. Treatments are as
follows: 1-control diet, 2-choline 500ppm, 3-choline 1000ppm, 4-betaine 500ppm, 5- betaine
1000ppm Data are least square means. Values not sharing letters are different (p<0.05)
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Table 4. Leg weight and leg percentage of total carcass for experiment 1

Treatment

leg weight

SEM
10.21
10.38
10.32
10.32
10.32

leg % of
carcass
26.1%a
26.1%a
26.1%a
26.9%a
26.1%a

1
2
3
4
5
Temperature
High
Temperature
Thermoneutral

577.12a
578.65a
573.38a
590.96a
585.83a

0.00434
0.00449
0.00449
0.00434
0.00441

589.42a

10.21

26.6%a

0.00280

572.96a

10.38

25.9%a

0.00278

Data are least square means
a
Values within same column not sharing letters are different (p<0.05)
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SEM

Leg Weight
700

A
600

B

AB

AB

AB

AB

AB

AB

A

AB
1 HS
1 TN

500
Grams (g)

2 HS
400

2 TN
3 HS

300

3 TN
4 HS

200

4 TN
5 HS

100
0

5 TN
Temperature x Treatment

Figure 2. Interaction between treatment and temperature for leg weight. Treatments are as
follows: 1-control diet, 2-choline 500ppm, 3-choline 1000ppm, 4-betaine 500ppm, 5- betaine
1000ppm Data are least square means. Values not sharing letters are different (p<0.05)
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Table 5. Breast weight and breast percentage of total carcass for experiment 1

Treatment

breast weight

SEM
16.734
16.910
16.905
16.818
16.905

breast % of
carcass
38.9%ab
38.8%ab
38.7%b
40.4%a
39.2%ab

1
2
3
4
5
Temperature
High
Temperature
Thermoneutral

861.14a
869.51a
853.85a
889.4a
858.75a

0.00611
0.00631
0.00631
0.00607
0.00620

854.52a

10.681

38.7%a

0.00394

878.54a

10.661

39.7%a

0.00390

Data are least square means
a
Values within same column not sharing letters are different (p<0.05)
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SEM

Breast Weight
1000

Grams (g)

900

AB

AB

B

AB

AB

AB

AB

A

AB

AB
1 HS

800

1 TN

700

2 HS

600

2 TN

500

3 HS
3 TN

400

4 HS
300

4 TN

200

5 HS

100

5 TN

0

Temperature x Treatment

Figure 3. Temperature and treatment interaction for breast weight. Treatments are as follows: 1control diet 2-choline 500ppm, 3-choline 1000ppm, 4-betaine 500ppm, 5- betaine 1000ppm Data
are least square means. Values not sharing letters are different (p<0.05)
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Table 6. Percentage of muscle as a function of carcass weight

Treatment

Muscle % of carcass

SEM

1

65.08%ab

0.01003

2

64.93%ab

0.01036

3

64.78%ab

0.01036

4

67.44%a

0.01003

5

64.19%b

0.01019

High Temperature

64.88%a

0.00648

Thermoneutral

65.68%a

0.00642

Temperature

Data are least square means
a
Values within same column not sharing letters are different (p<0.05)
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Table 7. Abdominal Fat pad weight and percentage of total carcass
Treatment

Abdominal fat

Ab fat % of carcass

1

35.9393ab

1.7%ab

2

38.1879a

1.8%a

3

33.4999b

1.5%ab

4

35.7442ab

1.6%ab

5

35.611ab

1.6%ab

35.6534a

1.6%a

35.9395a

1.6%a

Temperature
High
Temperature
Thermoneutral

Data are least square means
a
Values within same column not sharing letters are different (p<0.05)

36

Abdominal Fat
45
40

A

A
A

A

A
A

A

35

A

A
A

1 HS
1 TN

Grams (g)

30

2 HS
2 TN

25

3 HS
20

3 TN

15

4 HS
4 TN

10

5 HS
5 TN

5
0

Temperature x Treatment

Figure 4. Temperature and treatment interaction for abdominal fat. Treatments are as follows: 1control diet, 2-choline 500ppm, 3-choline 1000ppm, 4-betaine 500ppm, 5- betaine 1000ppm
Data are least square means. Columns not sharing letters are different (p<0.05).
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Glucose, NEFA, and triglyceride concentrations were measured in the serum of chickens
slaughtered at 44 days of age. Figure 5 shows the concentration of NEFA in 44 day-old broilers
fed with the two betaine diets and the control diet. Supplementation of betaine significantly
altered NEFA in chickens (p< 0.05). Betaine did not, however, have an effect on triglyceride
concentration (p>0.16) .
As expected, supplementation of betaine did not have an effect on glucose concentrations
(p>0.20), indicating that betaine did not disrupt the normal metabolic state.
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NEFA Concentration
0.6

A
0.5

AB

B
NEFA (g/dl)

0.4

0.3

0.2

0.1

0
control (methionine sufficient)

betaine low (.6g/kg)

betaine high (1.2g/kg)

Figure 5. Serum NEFA concentration of 44 day old broilers treated with betaine. Data are least
square means and columns not sharing letters are different (p<0.05)
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Triglyceride Concentration
0.06

A

A
0.05

A

TG (g/dl)

0.04

0.03

0.02

0.01

0
control (methionine deficient)

betaine low (.6g/kg)

betaine high (1.2g/kg)

Figure 6. Serum triglyceride concentration of 44 day old broilers treated with betaine.
Data are least square means and columns not sharing letters are different (p<0.05)
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Glucose Concentration
1.4

A
1.2

A

A

Glu (g/dl)

1
0.8
0.6
0.4
0.2
0
control (methionine sufficient)

betaine low (.6g/kg)

betaine high (1.2 g/kg)

Figure 7. Serum glucose concentration of 44 day old broilers treated with betaine. Data are least
square means and columns not sharing letters are different (p<0.05)
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Ex Vivo Stimulation of Lipolysis
Media concentrations of glycerol and NEFA were used to determine the effects of
various treatments on lipolysis in chicken adipose explants. One hour treatment with Isobutyl-1methylxanthine

and

glucagon

significantly

increased

media

glycerol

concentration

(p<0.05;Figure 8). Both treatments also significantly increased NEFA concentration (Figure 10).
The effect of IBMX on glycerol persisted after six hours (p<0.05; Figure 9). NEFA levels after
six hours of glucagon treatment were significantly lower than controls (Figure 11). Isoproterenol
treatment did not stimulate lipolysis, based on NEFA and glycerol concentrations (Figures 8-11).
Betaine caused a significant increase in glycerol and NEFA concentrations after one hour of
treatment (p<0.05; Figure 12 and Figure 14, respectively). The effects of betaine were not
apparent after 24 hours of treatment (Figure 13and 15).
The addition of BSA led to increased non-esterified fatty acids in media. This is due to
albumin acting as a “NEFA trap” in the media. Albumin binds to free fatty acids as a means of
transportation (Spector 1975). Because of this a source of albumin either from bovine, human or
mouse should be added when measuring NEFA concentration of media. The effects of BSA on
media glycerol and NEFA concentrations are shown in Figures 16-19. As shown in Figures 16
and 17, there was no consistent effect of BSA supplementation on glycerol release. However,
the addition of BSA significantly increase the media NEFA concentration, even in the absence of
stimulation, as shown in the controls (Figure 18 and 19). In each treatment, BSA significantly
increased the effect of treatment on NEFA concentration. When BSA was present in the media,
betaine significantly increase NEFA release after both one and six hours of treatment (p<0.05,
Figure 18 and 19, respectively). The effect of IBMX is inconsistent at times but this could be
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due to its tendency to fall out of solution when frozen and difficulty in confirming visually that it
was completely solubilized upon thawing.
Bezafibrate and TO-901317 significantly increased glycerol within the media following a
six hour incubation ( p<0.05, Figure 22). When compared to their vehicle specific control TO901317 and bezafibrate caused a 3.6 and 1.8 fold increase in glycerol respectively. This indicates
that the Liver X receptor alpha and Peroxisome Proliferator Receptor Activator delta are active
and stimulating lipolysis within the adipocyte.
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Media Glycerol Concentration
0.6

A
A

Glycerol (mg/ml/g)

0.5

0.4
B
0.3

B

0.2
CD

CD

0.1
D
0
control

isoproterenol isoproterenol
10 uM
1 uM

Glucagon
500nM

Glucagon
500nM

IBMX 500nm IBMX 100nM

Figure 8. Effects of one hour treatment with lipolytic agents on media glycerol concentration
normalized for tissue weight per well (mg glycerol/ ml media/ g tissue). Glycerol is represented
as milligram per milliliter per gram of tissue. Treatment details can be found in Table 1 IBMX,
Isobutyl-1-methylxanthine. Data are least square means and columns not sharing letters are
different (p<0.05)
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Media Glycerol Concentration
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Figure 9. Effects of six hour treatment with lipolytic agents on media glycerol concentration
normalized for tissue weight per well (mg glycerol/ ml media/ g tissue). Treatment details can
be found in Table 1. IBMX; isobutyl-1-methylxanthine Data are least square means and
columns not sharing letters are different (p<0.05)
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Figure 10. Effects of one hour treatment with lipolytic agents on media NEFA. Normalized for
tissue weight( mg NEFA/dl media/ g tissue) NEFA is presented as grams per deciliter per gram
of tissue. Treatment details can be found in Table 1. IBMX; isobutyl-1-methylxanthine. Data
are least square means and columns not sharing letters are different (p<0.05)
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Figure 11 Effects of six hour treatment with lipolytic agents on media NEFA concentration
normalized for tissue weight per well (mg glycerol/dl media/g tissue). Treatment details can be
found in Table 1. IBMX; isobutyl-1-methylxanthine Data are least square means and columns
not sharing letters are different (p<0.05)
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Figure 12. Glycerol concentration of explant media following one hour incubation
Effects of one hour treatment with lipolytic agents and betaine on media glycerol concentration
(mg glycerol/ml media).Treatment details can be found in Table 1. Data are least square means
and columns not sharing letters are different (p<0.05)
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Figure 13. Glycerol concentration of explant media following twenty-four hour incubation
Effects of twenty-four hour treatment with lipolytic agents and betaine on media glycerol
concentration (mg glycerol /ml media). Treatment details can be found in Table 1. Data are least
square means and columns not sharing letters are different (p<0.05)

49

Media NEFA Concentration
0.14

NEFA (g/dl)

0.1
0.08

A

A

0.12

C

C

control

glucagon
100nM

AB

AB

betaine
20mM

IBMX
500nM

BC

0.06
0.04
0.02
0
glucagon
500nM

betaine 2mM

IBMX
100nM

Figure 14. Effects of one hour treatment with lipolytic agents and betaine on media NEFA
concentration. Treatment details can be found in Table 1. Data are least square means and
columns not sharing letters are different (p<0.05)
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Figure 15. The effects of twenty four hour treatment of explants with lipolytic agents and
betaine on media NEFA concentration. Treatment details can be found in Table 1. Data are
least square means and columns not sharing letters are different (p<0.05)
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Figure 16. Effects of one hour treatment with lipolytic agents, with or without BSA (3%) and
betaine on media glycerol concentration (mg glycerol/ml media). Treatment details can be found
in Table 1. Data are least square means and columns not sharing letters are different (p<0.05)
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Figure 17. Effects of six hour treatment with lipolytic agents and betaine, with or without BSA
(3%) on media glycerol concentration. Treatment details can be found in Table 1.IBMX;
isobutyl-1-methylxanthine. Data are least square means and columns not sharing letters are
different (p<0.05)
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Figure 18. Effects of one hour treatment with lipolytic agents and betaine, with or without BSA
(3%), on media NEFA (mg NEFA/ml media). Treatment details can be found in Table 1. Data
are least square means and columns not sharing letters are different (p<0.05)
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Figure 19. Effects of 6 hour treatment with lipolytic agents and betaine, with or without BSA
(3%), on media NEFA concentration (mg NEFA/ml media). Treatment details can be found in
Table 1. Data are least square means and columns not sharing letters are different (p<0.05
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Figure 20.The effect of one hour treatment with nuclear receptors on media glycerol (mg
glycerol/ ml media). Treatment details can be found in Table 1.Data are least square means and
columns not sharing letters are different (p<0.05)
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Figure 21.The effect of twenty- four hour treatment with nuclear receptor agonist on media
glycerol (mg glycerol/ml media). Treatment details can be found in Table 1. Data are least
square means and columns not sharing letters are different (p<0.05)
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Figure 22. The effect of six hour treatment with nuclear receptor agonists on media glycerol (mg
glycerol/ml media). Treatment details can be found in Table 1. Data are least square means and
columns not sharing letters are different (p<0.05)
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Figure 23. The effect of 24 hour treatment with nuclear receptor agonists on media glycerol (mg
glycerol/ml media). Treatment details can be found in Table 1. Data are least square means and
columns not sharing letters are different (p<0.05)
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Chapter 5 Discussion
Betaine could prove to be an extremely useful tool in carcass modification as consumer
wants and needs fluctuate. It appears as if manipulation of the cAMP dependent process of
lipolysis is possible and relatively easy to accomplish. Diet is the most ideal method for
initiation of lipolysis.

With growing consumer consciousness associated with genetically

modified organisms it is imperative that any act, intended to change the bodily composition of an
agricultural animal, be received positively by the public. So long as wholesome foods and
components are used any dietary treatment should fill this niche.
Betaine is attractive as a supplement because it occurs naturally in avian kidney cells as
an osmoprotectant (Lien et al. 1993). Betaine can also spare if not replace methionine in the diet
and has been shown to increase breast weight in broilers (Zhan et al. 2006). However, the
mechanism by which betaine modifies the carcass is unknown. Betaine did not affect the carcass
performance of broilers (Experiment 1) but there was an effect of betaine on circulating nonesterified fatty acids. The effect is unclear because the lower concentration of betaine caused a
greater accumulation of NEFA than the higher betaine concentration (Figure 5). While betaine
has been documented to reduce the adiposity of chickens (Zhan et al. 2006) itis unclear whether
the fat was oxidized or deposited elsewhere. Itis possible that the increase in tissue weight is due
to an increase in lipid content of those tissues. More probable is that the lipid is never transported
from the liver. Therefore, it can be assumed that betaine’s role in lipid metabolism exists in
lipogenesis, transportation and storage rather than lipolysis and beta oxidation. If this is the case
then betaine’s use as a carcass modifier will depend on the fate of the animals. A deficiency in
fatty acid transport could lead to a pathological increase in fat within the liver. In the case of
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broilers, who have a relatively short life span, this would not be an issue, but an attempt to mimic
BHMT deficiency in other animals that will live longer lives may be problematic.
3-Isobutyl-1-methylxanthine (IBMX) and betaine clearly have the greatest impact on
lipid metabolism given the data presented. While IBMX is a noted phosphodiesterase inhibitor it
is not yet known how betaine affects lipid metabolism. However, even though the mechanism is
not understood it is clear that the end result, elevated NEFA concentration, is similar to
glucagon. A mimicked response to a naturally occurring hormone is one step closer to a natural
means of reducing adiposity. The nucleic receptors did not provide as drastic of a change in
NEFA and glycerol concentrations observed with betaine and IBMX but, the results are still
promising.

TO-901317 and bezafibrate Table 1 exhibited the greatest effect on glycerol

indicating an increase in lipolysis.
Lipolysis, the breakdown of triglycerides, results in the release of NEFA and a glycerol
backbone. Elevated NEFA in circulation is attributed to leanness (Ji et al. 2012). In the studies
described previously, certain treatments caused an increase in NEFA concentration. The drugs
used as treatments are not ideal for achieving the goal of dietary manipulation using natural
ingredients, but there are natural alternatives that can be used to obtain similar results. The
success of IBMX as a stimulator of lipolysis indicates that phosphodiesterase inhibition maybe
the lynchpin of lipolytic stimulation in the adipocyte. Caffeine, a natural phosphodiesterase
inhibitor, is the first candidate that comes to mind for future studies. If added in the form of tea
leaves or coffee, there exists the possibility for powerful natural stimulator of lipolysis.
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It must also be considered that betaine may play a role in fatty acid synthesis. When
insulin resistant HepG2 cells were treated with betaine at varying concentrations, AMPK
phosphorylation was suppressed. This suggests that betaine might reduce hepatic fat synthesis
(Kathirvel et al. 2010).

Betaine hydroxy-methyl transferase deficiency leads to impaired

triacylglycerol synthesis and enhanced glucose oxidation in isolated mature adipocytes, as well
as, impaired triacylglycerol oxidation in liver homogenates (Teng et al. 2012).
In the case of TO-901317 and bezafibrate another ligand must be found for LXRα and
PPARβ, respectively. The LXRα can be activated by oxysterols(oxidized cholesterol), and
PPARβ can be activated via long chain fatty acids and eicosanoids. It can be assumed that
supplementing the diet with either oxysterols, long chain fatty acids or eicosanoids will result in
a similar response compared the supplementation of their pharmaceutical counterpart.
Lipotoxcity is the next obstacle to overcome if dietary carcass modification is to be
achieved. In a normal fed animal, approximately 0.2% of endogenous fatty acids are oxidized,
50.1% are released, and 49.7% are re-esterified. Fasting doubles the partitioning of fatty acids
toward oxidation in association with a 1.4-fold increase in lipolysis (Wang et al. 2003). The
body is fine tuned to these specifications and an increase in lipid within tissue can lead to cellular
dysfunction and apoptosis (Schaffer 2003). Therefore, the fate of free fatty acids following
induced lipolysis is of concern. Overloading of the oxidative machinery could result in increased
re-esterification which is counterproductive if the end goal is reduction of whole body lipid
composition.
The real world possibility of using lipolysis as a tool to reduce adiposity in broilers is
high. It is clear from the data that manipulation of the cAMP cascade can induce a lipolytic
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state, and it is also clear that LXRα and PPARβ also play a role in the regulation of lipolysis.
While these statements have been validated in vitro it is still unclear what happens in the whole
bird. To test this, an ambitious, multifaceted live bird trial would be ideal. Such an experiment
would be performed, as follows:
First, a small pilot study using a small number of chicks will be performed. The chicks
would be slaughtered and their fat will be harvested and cultured using the protocol proposed
previously. The fat will be treated using IBMX, TO-901317, and bezafibrate, just as before.
However, caffeine, and a cocktail of long-chain polyunsaturated fatty acids would also be used
as treatments to ascertain their efficacy in vitro. Second, assuming that caffeine and the long
chain polyunsaturated fatty acids are effective substitutes for IBMX and the nuclear receptor
agonists.

A large scale broiler study using one-thousand birds per treatment will be

implemented. Proposed treatments are as follows:
1. Control - basal diet with choline level formulated to NRC level
2. Betaine - basal diet supplemented to provide 0.6g/kg of betaine. This diet will assess
the ability of betaine to serve as a method to augment lipogenesis and transport
3. PUFA- basal diet supplemented with a source of long chain poly unsaturated fatty
acids. Examples of sources include: flax seed, safflower oil and fish oil. This diet
will used as an activator for Liver X Receptor
4. PUFA + Betaine- basal diet supplemented with both betaine and a PUFA source. This
diet will be used to test if there is a compounded effect of feeding a PUFA source and
betaine.

Phase feeding will be utilized and samples will be taken at each phase. Blood will be
used to measure NEFA, glycerol, glucose and triglycerides. Liver biopsies will be taken to
measure fatty acid content of the liver this will serve as an indication of fatty acid delivery. Fat
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biopsies will be used histologically to measure adipocyte size to approximate the amount of lipid
being stored by the birds. Fat and liver will be snap frozen for future analysis of gene expression
primarily those associated with the Liver X receptor. Performing these tests at the changing of
the dietary phases will create a lipolytic time line for the lifetime of a broiler allowing producers
to pinpoint the ideal time for supplementation.
At the finisher phase a caffeine source will be added to test the efficacy of caffeine as a
lipolytic stimulus. The reason for adding caffeine at the end is because it is assumed that
caffeine will be the most powerful “fat burner”. The finishing phase is when the birds are
prepared for slaughter and if the birds are too lean during other phases, growth and flock health
could be compromised.
Slaughter provides the opportunity to study the effects of these diets on a fasted bird as
industry recommends a twenty four hour fast before slaughter. At slaughter a live weight will be
taken prior to kill. This allows for dressing percentage to be analyzed. Additional carcass
measurements will include: wing weight, breast percentage and leg quarter percentage. Muscle
will also be tested for enrichment of polyunsaturated fatty acids. Blood will be taken again for
post mortem analysis NEFA, glycerol, glucose and triglycerides. Fat and liver will be harvested
weighed and snap frozen for analysis of gene expression.
The future for the use of lipolysis as a tool for carcass modification is bright and success
of such a large scale experiment would cement the use of lipolysis as a means to improve both
profitability and marketability of the chicken. Proving the efficacy of caffeine and long chain
PUFAs will not only reduce the adiposity of the chicken, but if the meat is enriched with long
chain PUFAs chicken meat can be marketed as a healthy option much like eggs or milk enriched
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with omega-3 fatty acids. There would also be an increased demand in caffeine( tea or coffee),
flax, or safflower seeds adding value to these commodities as well.
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